Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Share of DNA Vaccines in Global Vaccine Market (%), 2016
Figure 5-2: Share of DNA Vaccines in Global Vaccine Market (%), 2022
Figure 5-3: Global - DNA Vaccine Market (Billion US$), 2016-2022
Figure 6-1: Global - DNA Vaccine Market by Geography (%), 2016
Figure 6-2: Global - DNA Vaccine Market by Geography (%), 2022
Figure 6-3: North America - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-4: Europe - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-5: Asia Pacific - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 7-1: Global - DNA Vaccine Market by Type (%), 2016
Figure 7-2: Global - DNA Vaccine Market by Type (%), 2022
Figure 7-3: Global - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-4: Global - Recombinant Protein Vaccines Market by Geography (%), 2016
Figure 7-5: Global - Recombinant Protein Vaccines Market by Geography (%), 2022
Figure 7-6: North America - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-7: Europe - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-8: Asia Pacific - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-9: Global - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-10: Global - Genetic Vaccines Market by Geography (%), 2016
Figure 7-11: Global - Genetic Vaccines Market by Geography (%), 2022
Figure 7-12: North America - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-13: Europe - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-14: Asia Pacific - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 8-1: Global - DNA Vaccine Market by End User (%), 2016
Figure 8-2: Global - DNA Vaccine Market by End User (%), 2022
Figure 8-3: Global - Human DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 8-4: Global - Animal DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 9-1: Global - DNA Vaccine Market by Therapeutic Segment (%), 2016
Figure 9-2: Global - DNA Vaccine Market by Therapeutic Segment (%), 2022
Figure 9-3: Global - DNA Vaccine Market for Infectious & Vector Borne Diseases (Billion US$), 2016 & 2022
Figure 9-4: Global - DNA Vaccine Market for Cancer (Billion US$), 2016 & 2022
Figure 10-1: Global - DNA Vaccine Pipeline Analysis by Phase (%), 2016
Figure 10-2: Global - DNA Vaccine Pipeline by Therapeutic Indication (%), 2016
Figure 10-3: Global - DNA Vaccine Pipeline by Vaccine Type (%), 2016
Figure 10-4: Global - DNA Vaccine Pipeline by Application (%), 2016
Figure 12-1: Novartis - Break-up of Revenue by Business Segment (%), 2019
Figure 12-2: Novartis - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-3: Merck & Co. Inc - Break-up of Revenue by Business Segment (%), 2019
Figure 12-4: Merck & Co. Inc - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-5: GlaxoSmithKline - Break-up of Revenue by Business Segment (%), 2019
Figure 12-6: GlaxoSmithKline - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-7: Sanofi - Break-up of Revenue by Business Segment (%), 2019
Figure 12-8: Sanofi - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-9: Zoetis - Break-up of Revenue by Business Segment (%), 2019
Figure 12-10: Zoetis - Break-up of Revenue by Geographical Region (%), 2019
Figure 12-11: Green Cross Corporation - Break-up of Revenue by Business Segment (%), 2019
 
List of Tables:

Table 10-1: Global - DNA Vaccines Pipeline
Table 12-1: Novartis International AG - Product Portfolio
Table 12-2: Novartis International AG - Pipeline Analysis
Table 12-3: Novartis - Key Financials (Million US$), 2017-2019
Table 12-4: Merck & Co. Inc - Product Portfolio
Table 12-5: Merck & Co. Inc - Key Financials (Million US$), 2017-2019
Table 12-6: GlaxoSmithKline - Product Portfolio
Table 12-7: GlaxoSmithKline - Key Financials (Million US$), 2017-2019
Table 12-8: Sanofi - Product Portfolio
Table 12-9: Sanofi - Pipeline Analysis
Table 12-10: Sanofi - Key Financials (Million US$), 2017-2019
Table 12-11: Zoetis - Product Portfolio
Table 12-12: Zoetis - Key Financials (Million US$), 2017-2019
Table 12-13: Green Cross Corporation - Product Portfolio
Table 12-14: Green Cross Corporation - Key Financials (Million US$), 2018 & 2019
Table 12-15: Inovio Pharmaceuticals - Key Financials (Million US$), 2015-2017
Table 12-16: Inovio Pharmaceuticals - Pipeline Analysis
Table 12-17: Bharat Biotech - Product Portfolio
Table 12-18: Indian Immunologicals Ltd. - Product Portfolio
Table 12-19: Serum Institute of India Pvt. Ltd - Product Portfolio
Table 12-20: Serum Institute of India Ltd. - Pipeline Analysis